Biocorrx Inc. (OTCMKTS:BICX – Get Free Report)’s stock price passed below its 200-day moving average during trading on Monday . The stock has a 200-day moving average of $0.34 and traded as low as $0.21. Biocorrx shares last traded at $0.21, with a volume of 320 shares changing hands.
Biocorrx Stock Performance
The business has a 50-day simple moving average of $0.29 and a 200 day simple moving average of $0.34. The firm has a market cap of $6.25 million, a P/E ratio of -1.75 and a beta of 0.19.
Biocorrx (OTCMKTS:BICX – Get Free Report) last issued its quarterly earnings data on Friday, August 14th. The company reported ($0.03) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.05) by $0.02. The business had revenue of $0.09 million during the quarter, compared to the consensus estimate of $0.24 million.
About Biocorrx
BioCorRx Inc, through its subsidiaries, develops and provides treatment programs for substance abuse and related disorders in the United States. It distributes and licenses BioCorRx recovery program, a non-addictive and medication-assisted treatment program that includes a counseling program coupled with its proprietary naltrexone implant; and distributes UnCraveRx weight loss management program, a medically assisted weight management program to reduce food cravings combined with on-demand virtual lifestyle support, fitness, and nutrition.
Featured Articles
- Five stocks we like better than Biocorrx
- Striking Oil: How the U.S. Play for Venezuela Fuels Supermajors
- J.M. Smucker Stock’s Rally Has More Than Tariffs Behind It
- Wendy’s Rally Fades After Trian Steps Back: Was It Ever Real?
- GitLab’s Earnings Beat Just Gave Software Bulls a New SaaSpocalypse Test
Receive News & Ratings for Biocorrx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Biocorrx and related companies with MarketBeat.com's FREE daily email newsletter.
